Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-11-27
2007-11-27
Duffy, Patricia A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S203100
Reexamination Certificate
active
10039760
ABSTRACT:
Compositions and methods for stimulating an immune response against a secreted enterohemorragicEscherichia coli(EHEC) antigen are disclosed. The compositions comprise EHEC cell culture supernatants.
REFERENCES:
patent: 5747309 (1998-05-01), Allan et al.
patent: 5951988 (1999-09-01), Littel-van den Hurk et al.
patent: 6136554 (2000-10-01), Bochner
patent: 59020226 (1984-02-01), None
patent: 99/24567 (1999-05-01), None
Li et al., Infection and Immunity vol. 68, No. 9, pp. 5090-5095, Sep. 2000.
Dean-Nystrom (Infection and Immunity, vol. 66, No. 9, pp. 4560-4563, 1998).
Hunt et al, J. Clin. Pathol., 42:847-852, 1989.
Kudva, (Diss. Abstr. Int., B 1998, 58(10):5252).
Kobayashi (JP 59020226, published Feb. 1, 1984; translation attached to original Japanese document).
Pokric (Periodicum Biologorium 101(4)283-302, 1999).
Allison (Methods: A Companion to Methods in Enzymology, 19:87-93, 1999).
Morein et al (Methods: A Companion to Methods in Enzymology, 19(1):94-102, 1999).
Harlow et al (Antibodies: A Laboratory Manual, Cold Spring Harbor Press, 1988, pp. 96-99).
Wilson et al (Journal of Food Protection, 60(11):1451-1453, 1997).
Conlan et al., “Oral immunization of mice with a glycoconjugate vaccine containing the O157 antigen ofEscherichia coliO157:H7 admixed with cholera toxin fails to elicit protection against subsequent colonization by the pathogen,”CAN J. Microbiol., 46:283-290(2000).
Conlan et al., “Parenteral immunization with a glycoconjugate vaccine containing the O157 antigen ofEscherichia coliO157:H7 elicits a systemic humoral immune response in mice, but fails to prevent colonization by the pathogen,”CAN J. Microbiol., 45:279-286(1999).
Conlon et al., “Efficacy of Recombinant Leukotoxin in Protection Against Pneumonic Challenge with Live Pasteurella Haemolytica A,”Infection and Immunity, 59(2)587-591 (1991).
DeVinney et al., “EnterohemorrhagicEscherichia coliO157:H7 Produces Tir, Which Is Translocated to the Host Cell Membrane but Is Not Tyrosine Phosphorylated,”Infect. Immun., 67:2389-2398 (1999).
Li et al., “Human Response toEscherichia coliO157:H7 Infection: Antibodies to Secreted Virulence Factors,”Infec. Immun., 68:5090-5095(2000).
van Drunen Littel-van den Hurk et al., “Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein glV,”Vaccine, 11:25-35(1993).
Finlay B. Brett
Potter Andrew A.
Duffy Patricia A.
University of British Columbia
University of Saskatchewan
Woodcock & Washburn LLP
LandOfFree
Enterohemorrhagic Escherichia coli vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enterohemorrhagic Escherichia coli vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enterohemorrhagic Escherichia coli vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3844317